The DOI matches its Crossref record; 267 of the 267 references it cites were found in a registry or an index.
Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries
Open accessAbstract
Interventional coronary reperfusion strategies are widely adopted to treat acute myocardial infarction, but morbidity and mortality of acute myocardial infarction are still high. Reperfusion injuries are inevitable due to the generation of reactive oxygen species (ROS) and apoptosis of cardiac muscle cells. However, many antioxidant and anti-inflammatory drugs are largely limited by pharmacokinetics and route of administration, such as short half-life, low stability, low bioavailability, and side effects for treatment myocardial ischemia reperfusion injury. Therefore, it is necessary to develop effective drugs and technologies to address this issue. Fortunately, nanotherapies have demonstrated great opportunities for treating myocardial ischemia reperfusion injury. Compared with traditional drugs, nanodrugs can effectively increase the therapeutic effect and reduces side effects by improving pharmacokinetic and pharmacodynamic properties due to nanodrugs' size, shape, and material characteristics. In this review, the biology of ROS and molecular mechanisms of myocardial ischemia reperfusion injury are discussed. Furthermore, we summarized the applications of ROS-based nanoparticles, highlighting the latest achievements of nanotechnology researches for the treatment of myocardial ischemia reperfusion injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–267 of 267
Lee, D., Bae, S., Ke, Q., Lee, J., Song, B., Karumanchi, S. A., Khang, G., Choi, H. S., & Kang, P. M. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.020 · Cited by 94
Fujiwara, M., Matoba, T., Koga, J., Okahara, A., Funamoto, D., Nakano, K., Tsutsui, H., & Egashira, K. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz066 · Cited by 94
Zhang, S., Wang, J., & Pan, J. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1223218 · Cited by 93
Lozano, O., Lázaro‐Alfaro, A., Silva‐Platas, C., Oropeza‐Almazán, Y., Torres‐Quintanilla, A., Bernal‐Ramírez, J., Alves‐Figueiredo, H., & García‐Rivas, G. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7683051 · Cited by 89
Cheng, Y., Liu, D., Zhang, C.-X., Cui, H., Liu, M., Zhang, B., Mei, Q., Lu, Z., & Zhou, S. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.12.014 · Cited by 85
Mitochondrial Calcium Handling in Physiology and Disease
Granatiero, V., Stefani, D. D., & Rizzuto, R. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55330-6_2 · Cited by 84
Nanoparticle-Mediated Drug Delivery System for Cardiovascular Disease
Matoba, T., & Egashira, K. (2014) · International Heart Journal · doi:10.1536/ihj.14-150 · Cited by 83
Nanotechnology in Diagnosis and Treatment of Coronary Artery Disease
Karimi, M., Zare, H., Nik, A. B., Yazdani, N., Hamrang, M., Mohamed, E., Zangabad, P. S., Basri, S. M. M., Bakhtiari, L., & Hamblin, M. R. (2016) · Nanomedicine · doi:10.2217/nnm.16.3 · Cited by 83
Hardy, N., Viola, H. M., Johnstone, V., Clemons, T. D., Szappanos, H. C., Singh, R., Smith, N. M., Iyer, K. S., & Hool, L. C. (2014) · ACS Nano · doi:10.1021/nn5061404 · Cited by 83
Sharma, A. K., Kumar, A., Sahu, M., Sharma, G., Datusalia, A. K., & Rajput, S. K. (2018) · Microvascular Research · doi:10.1016/j.mvr.2018.06.003 · Cited by 83
Verma, D. D., Hartner, W. C., Thakkar, V., Levchenko, T. S., & Torchilin, V. P. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9334-0 · Cited by 79
Antioxidant Cerium Oxide Nanoparticle Hydrogels for Cellular Encapsulation
Weaver, J. D., & Stabler, C. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.01.017 · Cited by 79
Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities
Hajipour, M. J., Mehrani, M., Abbasi, S. H., Amin, A., Kassaian, S. E., Garbern, J. C., Caracciolo, G., Zanganeh, S., Chitsazan, M., Aghaverdi, H., et al. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00323 · Cited by 79
Shao, L., Ping, Z., & Jin, G. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9863181 · Cited by 76
Targeted pharmacotherapy for ischemia reperfusion injury in acute myocardial infarction
Rout, A., Tantry, U. S., Novaković, M., Sukhi, A., & Gurbel, P. A. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1787987 · Cited by 76
CoQ10Function and Role in Heart Failure and Ischemic Heart Disease
Ayer, A., Macdonald, P. S., & Stocker, R. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071714-034258 · Cited by 74
Leukocyte iNOS is required for inflammation and pathological remodeling in ischemic heart failure
Kingery, J. R., Hamid, T., Lewis, R. K., Ismahil, M. A., Bansal, S. S., Rokosh, G. D., Townes, T. M., Ildstad, S. T., Jones, S. P., & Prabhu, S. D. (2017) · Basic Research in Cardiology · doi:10.1007/s00395-017-0609-2 · Cited by 73
Xue, X., Shi, X., Dong, H., You, S., Cao, H., Wang, K., Wen, Y., Shi, D., He, B., & Li, Y. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.12.004 · Cited by 73
Siu, K. L., Lotz, C., Ping, P., & Cai, H. “. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.07.005 · Cited by 72
Fukuta, T., Asai, T., Sato, A., Namba, M., Yanagida, Y., Kikuchi, T., Koide, H., Shimizu, K., & Oku, N. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.04.046 · Cited by 71
Cardioprotection of Tetrahedral DNA Nanostructures in Myocardial Ischemia-Reperfusion Injury
Zhang, M., Zhu, J., Qin, X., Zhou, M., Zhang, X., Gao, Y., Zhang, T., Xiao, D., Cui, W., & Cai, X. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b10645 · Cited by 71
Yang, J., Brown, M. E., Zhang, H., Martinez, M. D., Zhao, Z., Bhutani, S., Yin, S., Trac, D. Q., Xi, J., & Davis, M. E. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00685.2016 · Cited by 70
Developing injectable nanomaterials to repair the heart
Nguyen, M. M., Gianneschi, N. C., & Christman, K. L. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.03.016 · Cited by 68
Jia, L., Wang, Y., Wang, Y., Ma, Y., Shen, J., Fu, Z., Wu, Y., Su, S., Zhang, Y., Cai, Z., et al. (2018) · Circulation Research · doi:10.1161/circresaha.118.312910 · Cited by 67
Yang, Y., Shi, C., Hou, X., Zhao, Y., Chen, B., Tan, B., Deng, Z., Li, Q., Liu, J., Xiao, Z., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.036 · Cited by 64
Self-citationPotential therapeutic roles of stem cells in ischemia-reperfusion injury
Barzegar, M., Kaur, G., Gavins, F. N. E., Wang, Y., Boyer, C. J., & Alexander, J. S. (2019) · Stem Cell Research · doi:10.1016/j.scr.2019.101421 · Cited by 64
Vendrov, A. E., Sumida, A., Canugovi, C., Lozhkin, A. P., Hayami, T., Madamanchi, N. R., & Runge, M. S. (2018) · Redox Biology · doi:10.1016/j.redox.2018.11.021 · Cited by 63
An inflammation-inducible adenoviral expression system for local treatment of the arthritic joint
van de Loo, F., Hooge, A. D., Smeets, R. L., Bakker, A., Bennink, M., Arntz, O., Joosten, L., van Beuningen, H., van der Kraan, P., Varley, A. W., et al. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302182 · Cited by 61
Biary, N., Xie, C., Kauffman, J., & Akar, F. G. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.214239 · Cited by 58
Andrienko, T., Pasdois, P., Rossbach, A. M., & Halestrap, A. P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167300 · Cited by 58
Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition
Ibarrola, J., Matilla, L., Martínez‐Martínez, E., Gueret, A., Fernández‐Celis, A., Henry, J., Nicol, L., Jaisser, F., Mulder, P. G. H., Ouvrard‐Pascaud, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46119-6 · Cited by 58
Lin, Y., Liu, J., Bai, R., Shi, J., Zhu, X., Liu, J., Guo, J. R., Zhang, W., Liu, H., & Liu, Z. (2020) · ACS Nano · doi:10.1021/acsnano.0c04727 · Cited by 56
Self-citationReinforcing nanomedicine using graphene family nanomaterials
Jaleel, J. A., Sruthi, S. N., & Pramod, K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.041 · Cited by 55
Myocardial ischemia and reperfusion: The role of oxygen radicals in tissue injury
Werns, S. W., & Lucchesi, B. R. (1989) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00133206 · Cited by 54
Tranter, M., Liu, Y., He, S., Gulick, J. M., Ren, X., Robbins, J. M., Jones, W. K., & Reineke, T. M. (2011) · Molecular Therapy · doi:10.1038/mt.2011.267 · Cited by 53
Progress in Therapies for Myocardial Ischemia Reperfusion Injury
Chi, H., Chen, M., Yang, X., Lin, X., Sun, H., Zhao, W., Qi, D., Dong, J.-L., & Cai, J. (2016) · Current Drug Targets · doi:10.2174/1389450117666160401120308 · Cited by 51
Zhang, T., Dang, M., Zhang, W., & Lin, X. (2019) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2019.111705 · Cited by 51
Milliken, A. S., Kulkarni, C. A., & Brookes, P. S. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101733 · Cited by 48
Nanotechnology-based siRNA delivery strategies for metastatic colorectal cancer therapy
Sousa, A. R., Oliveira, A. V., Oliveira, M. J., & Sarmento, B. F. C. C. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118530 · Cited by 47
Nanomedicine in coronary artery disease
Ambesh, P., Campia, U., Obiagwu, C., Bansal, R., Shetty, V., Hollander, G. M., & Shani, J. (2017) · Indian Heart Journal · doi:10.1016/j.ihj.2017.02.007 · Cited by 46
Wang, S., Li, L., Liu, T., Jiang, W., & Hu, X. (2020) · Regenerative Medicine · doi:10.2217/rme-2019-0136 · Cited by 46
Ichimura, K., Matoba, T., Nakano, K., Tokutome, M., Honda, K., Koga, J., & Egashira, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162425 · Cited by 45
Shen, Y., Gong, S., Li, J., Wang, Y., Zhang, X., Zheng, H., Zhang, Q., You, J., Huang, Z., & Chen, Y. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s209820 · Cited by 45
Reduction by SEA0400 of myocardial ischemia-induced cytoplasmic and mitochondrial Ca2+ overload
Namekata, I., Shimada, H., Kawanishi, T., Tanaka, H., & Shigenobu, K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.012 · Cited by 44
Nanoparticle–Hydrogel System for Post-myocardial Infarction Delivery of MicroRNA
Bheri, S., & Davis, M. E. (2019) · ACS Nano · doi:10.1021/acsnano.9b05716 · Cited by 44
Gray, W. D., Che, P.-L., Brown, M. E., Ning, X., Murthy, N., & Davis, M. E. (2011) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-011-9292-0 · Cited by 43
Superparamagnetic iron oxide nanoparticles promote ferroptosis of ischemic cardiomyocytes
Zheng, H., You, J., Yao, X., Lu, Q., Guo, W., & Shen, Y. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15722 · Cited by 43
Treatment of Oxidative Stress with Exosomes in Myocardial Ischemia
Liu, Y., Wang, M., Liang, Y., Wang, C., Naruse, K., & Takahashi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041729 · Cited by 42 · cited 2×
“miRNA-19a/19b can induce the proliferation of cardiomyocytes and promote cardiac regeneration [266].”
BackgroundNanomedicine for the cardiac myocyte: Where are we?
Lozano, O., Torres‐Quintanilla, A., & García‐Rivas, G. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.018 · Cited by 40
Targeting NOX 4 by petunidin improves anoxia/reoxygenation-induced myocardium injury
Cai, X., Yang, C., Shao, L., Zhu, H., Wang, Y., Huang, X. B., Wang, S., & Hong, L. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173414 · Cited by 40
Biomechanical Regulation of Mesenchymal Stem Cells for Cardiovascular Tissue Engineering
Henderson, K., Sligar, A. D., Le, V., Lee, J., & Baker, A. B. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700556 · Cited by 37
NADPH oxidases in the differentiation of endothelial cells
Hahner, F., Moll, F., & Schröder, K. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz213 · Cited by 37
Zhang, Y., Qian, P., Zhou, H., Shen, R., Hu, B., Shen, Y., Zhang, X., Shen, X., Xu, G., & Jin, L. (2018) · Kidney & Blood Pressure Research · doi:10.1159/000492409 · Cited by 34
Clemons, T. D., Viola, H. M., House, M. J., Iyer, K. S., & Hool, L. C. (2013) · ACS Nano · doi:10.1021/nn305211f · Cited by 32
Cardiovascular protection by Nox4
Morawietz, H. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvx252 · Cited by 32
Saludas, L., Garbayo, E., Mazo, M. M., Pelacho, B., Abizanda, G., Iglesias‐García, O., Raya, Á., Prósper, F., & Blanco‐Prieto, M. J. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.256065 · Cited by 31
Prostacyclin Analogue–Loaded Nanoparticles Attenuate Myocardial Ischemia/Reperfusion Injury in Rats
Yajima, S., Miyagawa, S., Fukushima, S., Sakai, Y., Iseoka, H., Harada, A., Isohashi, K., Horitsugi, G., Mori, Y., Shiozaki, M., et al. (2019) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2018.12.006 · Cited by 28
Pharmacological preconditioning by diazoxide downregulates cardiac L‐type Ca2+ channels
González, G., Zaldivar, D., Carrillo, E. G., Hernández, A., García, M. C., & Sánchez, J. A. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00960.x · Cited by 27
Antioxidant efficacy of chitosan/graphene functionalized superparamagnetic iron oxide nanoparticles
Hastak, V., Bandi, S., Kashyap, S., Singh, S., Luqman, S., Lodhe, M., Peshwe, D. R., & Srivastav, A. K. (2018) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-018-6163-0 · Cited by 27
Markevich, N. I., Galimova, M. H., & Markevich, L. N. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101630 · Cited by 27
Viola, H. M., Jordan, M. C., Roos, K. P., & Hool, L. C. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.000961 · Cited by 25
Naseroleslami, M., Aboutaleb, N., & Mokhtari, B. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00788-3 · Cited by 24
The Potential for Nanotechnology to Improve Delivery of Therapy to the Acute Ischemic Heart
Evans, C. W., Iyer, K. S., & Hool, L. C. (2016) · Nanomedicine · doi:10.2217/nnm.16.7 · Cited by 23
Zhang, L., Zhang, Y., Yu, X., Xu, H., Sui, D., & Zhao, X. (2018) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-865020180120000004 · Cited by 23
Soumya, R. S., Prathapan, A., Raj, P. S., Vineetha, V. P., & Raghu, K. G. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.08.172 · Cited by 21
Calcium antagonists in myocardial ischemia/reperfusion—update 2012
Kleinbongard, P., Baars, T., & Heusch, G. (2012) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-012-0113-0 · Cited by 12
Basu, A., Jain, N., Tolbert, B. S., Komar, A. A., & Mazumder, B. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx979 · Cited by 11
Cited by
Macrophages in immunoregulation and therapeutics
Chen, S., Saeed, A. F. U. H., Liu, Q., Jiang, Q., Xu, H., Xiao, G. G., Rao, L., & Duo, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01452-1 · Cited by 2,229
Chen, Q., Zheng, A., Xu, X., Shi, Z., Yang, M., Sun, S., Wang, L., Wang, Y., Zhao, H., Xiao, Q., et al. (2025) · Circulation · doi:10.1161/circulationaha.124.070286 · Cited by 54
Emerging technologies for cardiac tissue engineering and artificial hearts
Sun, L., Wang, Y., Xu, D., & Zhao, Y. (2023) · Smart Medicine · doi:10.1002/smmd.20220040 · Cited by 44
Liu, J., Zhao, L., Sun, Y., Fu, Q., & Xiao, W. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102186 · Cited by 9
“…of neurodegenerative diseases, their ability to cross the blood-brain barrier holds promise for targeted drug delivery in Alzheimer ’ s disease [198 – 201]; and in precision imaging diagnostics, gadolinium/hafnium-based materials ’ bimodal imaging potential could improve early lesion detection…”
Self-citation
Metadata
- Authors
- Zhao, T., Wu, W., Sui, L., Huang, Q., Nan, Y., Liu, J., & Ai, K.
- Venue
- Bioactive Materials
- Publisher
- Elsevier BV
- Published
- 2022-01
- Volume
- 7
- Pages
- 47-72
- ISSN
- 2097-1192 (ISSN-L)
- 2452-199X
- OpenAlex
- W3176618862
- Cited by
- 267
- References
- 267
- FWCI
- 28.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.